Search
Returning search results with filters:
Remove filter for
Category: Biologic or vaccine
Remove filter for
Issue: COVID
Remove filter for
Last updated: 2021
Remove filter for
Type: Alert
Clear all
Type
Audience
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 15 of 17 items.
Health Canada is informing Canadians and healthcare professionals about changes to the product labels of the Janssen and Vaxzevria (AstraZeneca) COVID-19 vaccines.
The Department is updating the label of the Janssen COVID-19 Vaccine to provide…
AlertPublic advisory | 2021-11-09
Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic
Starting date:
September 22, 2021
Posting date:
October 4, 2021
Type of communication:…
AlertHealth professional risk communication | 2021-10-04
Health Canada updates Pfizer-BioNTech COVID-19 vaccine label to reflect very rare reports of Bell's Palsy
Starting date:
August 6, 2021
Type of communication:
Advisory…
AlertPublic advisory | 2021-08-06
Health Canada updates Pfizer-BioNTech and Moderna COVID-19 vaccine labels to include information on myocarditis and pericarditis
Starting date:
June 30, 2021
Posting date:…
AlertPublic advisory | 2021-06-30
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Capillary Leak Syndrome
Starting date:
June 29, 2021
Posting date:
June 29, 2021
Type of communication:
Dear Healthcare…
AlertHealth professional risk communication | 2021-06-29
Health Canada issues label change on the AstraZeneca and COVISHIELD COVID-19 vaccines
Starting date:
April 14, 2021
Posting date:
June 29, 2021
Type of communication:
Advisory…
AlertPublic advisory | 2021-06-29
UPDATED INFORMATION – October 29, 2021
Further to the Health Canada communications below issued on June 14, 2021 (and updated on June 24, 2021, and August 3, 2021), Health Canada has authorized a 2-month shelf life extension (from 7 months to 9 months…
AlertHealth professional risk communication | 2021-06-14
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
Starting date:
April 28, 2021
Posting date:
April 28, 2021
Type of…
AlertHealth professional risk communication | 2021-04-28
Importation of Janssen COVID-19 Vaccine with Two Types of English-only Vial and Carton Labels
Starting date:
April 26, 2021
Posting date:
April 26, 2021
Type of communication…
AlertHealth professional risk communication | 2021-04-26
Janssen COVID-19 Vaccine and the Risk of Thrombosis with Thrombocytopenia
Starting date:
April 26, 2021
Posting date:
April 26, 2021
Type of communication:
Dear Healthcare…
AlertHealth professional risk communication | 2021-04-26
Importation of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels (US-Labelled Supply)
Starting date:
March 31, 2021
Posting date:
March 31, 2021
Type of…
AlertHealth professional risk communication | 2021-03-31
AstraZeneca COVID-19 Vaccine and COVISHIELD: Risk of Thrombosis with Thrombocytopenia
Starting date:
March 24, 2021
Posting date:
March 24, 2021
Type of communication:
Dear…
AlertHealth professional risk communication | 2021-03-24
Pfizer-BioNTech COVID-19 Vaccine: Updated Storage and Transportation Conditions
Starting date:
March 8, 2021
Posting date:
March 8, 2021
Type of communication:
Dear Healthcare…
AlertHealth professional risk communication | 2021-03-08
Authorization of Janssen COVID-19 Vaccine with English-only Vial and Carton Labels
Starting date:
March 5, 2021
Posting date:
March 8, 2021
Type of communication:
Dear…
AlertHealth professional risk communication | 2021-03-08
Authorization of AstraZeneca COVID-19 Vaccine with English-only Vial and Carton Labels
Starting date:
February 26, 2021
Posting date:
March 1, 2021
Type of communication:
Dear…
AlertHealth professional risk communication | 2021-03-01